Arkolith/Insider Trading/RAPP/Form 4

Yeleswaram Krishnaswamy

Chief Development OfficerRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Apr 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$696K
Net Open-Market Flow
-$696K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 14, 2026Sell(S)10K$35.08$358K267K
Apr 13, 2026Sell(S)9K$34.97$321K277K
Apr 10, 2026Sell(S)500$34.98$17K286K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-154908) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML